Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Aptose Biosciences Inc (APS)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create a new watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
4.29 +0.15    +3.62%
17/06 - Closed. Currency in CAD ( Disclaimer )
Type:  Equity
Market:  Canada
ISIN:  CA03835T2002 
CUSIP:  03835T200
  • Volume: 51,369
  • Bid/Ask: 4.27 / 4.30
  • Day's Range: 4.19 - 4.38
Aptose Biosciences 4.29 +0.15 +3.62%

APS News

 
This page features the latest news about the Aptose Biosciences stock.
Aptose Biosciences EPS misses by $0.01
Aptose Biosciences EPS misses by $0.01
By Seeking Alpha - May 04, 2021

Aptose Biosciences (APTO): Q1 GAAP EPS of -$0.18 misses by $0.01.Total cash and cash equivalents and investments as of March 31, 2021 were $112.1 million

Aptose Biosciences EPS in-line
Aptose Biosciences EPS in-line
By Seeking Alpha - Mar 23, 2021

Aptose Biosciences (APTO): Q4 GAAP EPS of -$0.17 in-line.Total cash and cash equivalents and investments as of December 31, 2020 were $122.4 million

Aptose Biosciences misses by $0.11
Aptose Biosciences misses by $0.11 By Seeking Alpha - May 10, 2018

Aptose Biosciences (NASDAQ:APTO): Q1 EPS of -$0.23 misses by $0.11.Cash and equivalents of $16.2MPress ReleaseNow read: AMAG Pharmaceuticals (AMAG) Presents At 43rd Annual Deutsche Bank (DE:DBKGn)...

Premarket Gainers as of 9:05 am (03/07/2018)
Premarket Gainers as of 9:05 am (03/07/2018) By Seeking Alpha - Mar 07, 2018

MOMO +13% on Q4 result.ADSK +11% on Q4 result.APTO +10% on Bio out-licenses APL-581 for up to $125M.ZSAN +8%.FORM +7% will join S&P Smallcap 600.MNGA +5% as green arc sales force to expand by 60%...

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

APS Comments

Write your thoughts about Aptose Biosciences Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Liew ST
Liew ST Jun 15, 2021 10:16AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
2021.06.14. Bought again @ 3.81 after the dive.
Reply
0 0
Report
Liew ST
Liew ST Jun 08, 2021 10:54AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
2021.06.08. Bought 3.80 and sold 6.80 in March 2021
Reply
0 0
Report
la la
la la Mar 31, 2021 5:59AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
target at about 11.40$
Reply
3 1
Report
Mke Gee
Mke Gee Mar 29, 2021 9:50AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
100% BUY! Check it out!
Reply
2 1
Report
Mke Gee
Mke Gee Mar 29, 2021 9:50AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
U wouldve made 5.78% on your money!
Reply
0 1
Report
Anthony Gautier
Anthony Gautier Dec 18, 2020 2:31PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Encouraging newsChairman, President and Chief Executive Officer. “We are encouraged by the continued increase in plasma exposure, and we hope the current and future dose levels will deliver formal responses to these deeply relapsed or refractory CLL patients. In AML, we are pleased by the observation of an anti-leukemic blast reduction from 93% to 10% in one of our first patients who was heavily pretreated with several consecutive FLT3 inhibitors. For APTO-253, we continue to escalate the dose and observe MYC repression, suggesting future potential for broad anti-cancer activity. We are pleased by such indicators of activity from both CG-806 and APTO-253, and we look forward to providing further updates in the first half of 2021 and at the Annual EHA Meeting 2021.”
Reply
2 2
Report
Anthony Gautier
Anthony Gautier Dec 16, 2020 12:28PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
APTO is a LT Stock, I see good things ahead as they get positive results from their studies..I have a good feeling about it, loaded up for LT at this price range
Reply
2 1
Report
Sky Emperor
SkyEmperor Dec 15, 2020 9:03AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I got in at 3.98, lets see how will it go
Reply
3 1
Report
Sky Emperor
SkyEmperor Nov 13, 2020 3:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Is time to buy?
Reply
4 0
Report
Longino Ojeda Sánchez
Longino Ojeda Sánchez Nov 13, 2020 3:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
wait
Reply
0 1
Report
James Kiz
James Kiz Nov 13, 2020 3:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
if you are interstates
Reply
0 0
Report
Mark Ranger
Mark Ranger Dec 09, 2019 11:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
BUY BUY BUY
Reply
4 0
Report
Jeff Lakatos
Jeff Lakatos Feb 09, 2017 11:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hello? Anybody out there? I bought this at $1.00 after it was announced they were going to stop working on one drug and switching focus to another which brought price way down.
Reply
5 3
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email